Filing Details
- Accession Number:
- 0001384101-18-000066
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-07-26 17:29:24
- Reporting Period:
- 2018-07-24
- Accepted Time:
- 2018-07-26 17:29:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1384101 | Veracyte Inc. | VCYT | Services-Medical Laboratories (8071) | 205455398 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1588970 | H Bonnie Anderson | 6000 Shoreline Court Suite 300 South San Francisco CA 94080 | Chairman And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-07-24 | 50 | $2.68 | 52,591 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-07-24 | 50 | $11.50 | 52,541 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2018-07-24 | 50 | $0.00 | 50 | $2.68 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
122,255 | 2022-03-10 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 99,085 | Indirect | The Bonnie H. Anderson Living Trust |
Footnotes
- The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 24, 2017.
- The option becomes exercisable as to 25% of the shares on March 10, 2013, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.